Experimental Alzheimer's Drug MK-8931 Moves To Late-Stage Trials
Merck shares slipped 0.4 percent to $49.35 in afternoon trading on the New York Stock Exchange, amid moderate declines for
experimental alzheimer drug mk move late stage trials merck share slip percent  afternoon trading new york stock exchange amid moderate decline